Wolverine Trading
AVEO

Wolverine Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Wolverine Trading’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,600
Closed -$98K – 7412
2021
Q3 		$98K Buy
+15,600
New +$93.3K ﹤0.01% 5787
2021
Q2 		– Sell
-30,200
Closed -$209K – 7151
2021
Q1 		$209K Buy
30,200
+11,600
+62% +$100K ﹤0.01% 5000
2020
Q4 		$106K Sell
18,600
-7,800
-30% -$44.7K ﹤0.01% 4455
2020
Q3 		$153K Buy
26,400
+6,400
+32% +$31.7K ﹤0.01% 3977
2020
Q2 		$102K Sell
20,000
-3,600
-15% -$22.7K ﹤0.01% 4128
2020
Q1 		$84K Buy
23,600
+20,300
+615% +$101K ﹤0.01% 4094
2019
Q4 		$21K Buy
3,300
+830
+34% +$6.11K ﹤0.01% 4546
2019
Q3 		$21K Sell
2,470
-940
-28% -$7K ﹤0.01% 4159
2019
Q2 		$23K Buy
+3,410
New +$29.2K ﹤0.01% 4278
2019
Q1 		– Sell
-25,010
Closed -$408K – 5659
2018
Q4 		$408K Buy
25,010
+16,250
+186% +$358K ﹤0.01% 2842
2018
Q3 		$290K Buy
8,760
+5,690
+185% +$146K ﹤0.01% 3774
2018
Q2 		$89K Hold
3,070
– – ﹤0.01% 4766
2018
Q1 		$89K Buy
+3,070
New +$89.8K ﹤0.01% 4766
2017
Q4 		– Sell
-6,210
Closed -$227K – 5798
2017
Q3 		$227K Buy
6,210
+4,180
+206% +$129K ﹤0.01% 3649
2017
Q2 		$43K Buy
+2,030
New +$16K ﹤0.01% 4085

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wolverine Trading's AVEO Position: Q3 2019 in Review

Wolverine Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2019, closing a stake of 1,385 shares — an estimated $10.3K sold.

Wolverine Trading first reported a position in AVEO in Q3 2016 and held it in 8 quarters. The position peaked at $198K in Q3 2017. 59 funds tracked by Wall St. Rank hold AVEO as of Q3 2019.

  • Wolverine Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Wolverine Trading sold 1,385 AVEO Pharmaceuticals, Inc. shares in Q3 2019, an estimated $10.3K.
  • Wolverine Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2016 and held it in 8 quarters.
  • Wolverine Trading's AVEO Pharmaceuticals, Inc. position peaked at $198K in Q3 2017.
  • 59 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2019.

Based on Wolverine Trading's 13F filing for Q3 2019, filed 14 Nov 2019.